tiprankstipranks
Teva Pharmaceutical (TEVA)
NYSE:TEVA

Teva Pharmaceutical (TEVA) Ownership - Who Owns Teva Pharmaceutical?

6,550 Followers

Teva Pharmaceutical (TEVA) Ownership Overview

0.66%16.15%2.91%80.28%
2.91% Other Institutional Investors
80.28% Public Companies and Individual Investors
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail and individual investors. Approximately 19.06% of the company’s stock is owned by Institutional Investors, 0.66% is owned by Insiders and 80.28% is owned by Public Companies and Individual Investors.
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail and individual investors. Approximately 19.06% of the company’s stock is owned by Institutional Investors, 0.66% is owned by Insiders and 80.28% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 21, 2024Sold$8838570
May 17, 2024Sold$470773
May 15, 2024
Conway Vikki L
Acting Head Of Global Human Resources
Sold$254766
Mar 07, 2024
Mark Sabag
Evp, International Markets
Sold$1352000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Bought$29659
Mar 31, 2024Sold$658386
Mar 31, 2024Bought$715377
Mar 31, 2024Sold$811959

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
58,734,848Institution5.19%1,014,938,173
39,840,286Institution3.52%688,440,142
26,896,184Institution2.37%464,766,060
22,429,902Institution1.98%387,588,707
17,949,245Institution1.58%310,162,954
14,000,000Institution1.24%241,920,000
8,387,420Institution0.74%144,934,618
7,501,284Institution0.66%129,622,188
6,727,432Institution0.59%116,250,025
5,996,836Institution0.53%103,625,326

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
58,734,848Institution5.19%1,014,938,173
39,840,286Institution3.52%688,440,142
17,949,245Institution1.58%310,162,954
14,000,000Institution1.24%241,920,000
8,387,420Institution0.74%144,934,618
6,727,432Institution0.59%116,250,025
5,007,700Institution0.44%86,533,056
3,500,000Institution0.31%60,480,000
3,370,318Institution0.30%58,239,095
3,311,633Institution0.29%57,225,018

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,805,915Institution0.60%115,564,437
3,583,476Institution0.32%61,277,440
1,988,454Institution0.18%34,002,563
1,399,404Institution0.12%23,761,880
1,284,996Institution0.11%21,973,432
1,253,449Institution0.11%21,433,978
936,422Institution0.08%16,012,816
797,797Institution0.07%13,642,329
727,569Institution0.06%12,441,430
643,536Institution0.06%11,120,302

FAQ

Who Owns Teva Pharmaceutical (TEVA)?
According to the latest TipRanks data, approximately 2.91% of the company's stock is held by institutional investors, 0.66% is held by insiders, and 80.28% is held by retail investors.
    What percentage of Teva Pharmaceutical (TEVA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.91% of Teva Pharmaceutical (TEVA) stock is held by institutional investors.
      What percentage of Teva Pharmaceutical (TEVA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 80.28% of Teva Pharmaceutical (TEVA) stock is held by retail investors.
        Who owns the most shares of Teva Pharmaceutical (TEVA)?
        Growth Fund of America owns the most shares of Teva Pharmaceutical (TEVA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis